Thomas Theriault
Fondateur chez Bullet Biotechnology, Inc.
Postes actifs de Thomas Theriault
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Bullet Biotechnology, Inc.
 Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Directeur Technique/Scientifique/R&D | 01/09/2011 | - |
| Fondateur | 01/09/2011 | - |
Historique de carrière de Thomas Theriault
Anciens postes connus de Thomas Theriault
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GENITOPE CORPORATION | Directeur Technique/Scientifique/R&D | 01/02/2005 | 31/03/2008 |
| INCYTE CORPORATION | Directeur Technique/Scientifique/R&D | 01/08/1996 | 01/04/2004 |
Combion, Inc.
 Combion, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Combion, Inc. is a company that develops ink-jet technology for a variety of high-density gridding synthesis applications. The company is based in Pasadena, CA. The company was founded by Thomas Theriault, John D. Baldeschwieler. Combion was acquired by Incyte Corp. on August 15, 1996 for $2.98 million. | Directeur Technique/Scientifique/R&D | 01/01/1996 | 01/01/1996 |
| Fondateur | 01/01/1996 | 01/01/1996 |
Formation de Thomas Theriault
| Dartmouth College | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| Entreprise privées | 3 |
|---|---|
Genitope Corp.
 Genitope Corp. BiotechnologyHealth Technology Genitope Corp. operates as a biotechnology company, which focuses on the research and development of novel immunotherapies for the treatment of cancer. The company was founded on August 15, 1996 and is headquartered in Redwood, CA. | Health Technology |
Combion, Inc.
Combion, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Combion, Inc. is a company that develops ink-jet technology for a variety of high-density gridding synthesis applications. The company is based in Pasadena, CA. The company was founded by Thomas Theriault, John D. Baldeschwieler. Combion was acquired by Incyte Corp. on August 15, 1996 for $2.98 million. | Commercial Services |
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Health Technology |
- Bourse
- Insiders
- Thomas Theriault
- Expérience
